|Page (1) of 1 - 04/13/11||email article||print page|
A Food and Drug Administration panel has voted to recommend for approval drugs from Pfizer (PFE) and Novartis (NVS) that treat a rare form of pancreatic cancer. Both drugs are under consideration to treat unresectable pancreatic neuroendocrine tumors.
|FDA Panel Votes to Recommend Pfizer, Novartis Drugs|
Source:Copyright (2011) Market News Video.. All Rights Reserved